InfuSystem Holdings, Inc. (INFU) Deep Dive Video

InfuSystem offers an underappreciated clinical-services re-rating story: a dominant outpatient oncology platform, expanding wound-care growth engine, improving margins, conservative leverage, insider buying, and a discounted valuation create asymmetric upside if execution remains on track.